ArticleFrontiers in immunology2026
Real-world experience with efgartigimod in generalized myasthenia gravis: a single-center retrospective study in China.
Zhenyu Niu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it